Fairness in Computational Innovations: Identifying Bias in Substance Use Treatment Length of Stay Prediction Models with Policy Implications
Ugur Kursuncu, Aaron Baird, Yusen Xia

TL;DR
This study examines biases in machine learning models predicting treatment length of stay for substance use disorder patients, highlighting fairness issues related to race, geography, and payment source, and proposing mitigation strategies.
Contribution
It develops and assesses ML models for LOS prediction in SUD treatment, identifying key sources of bias and suggesting policy-oriented mitigation strategies.
Findings
Race and geographic region are primary bias indicators.
Bias exists across demographic, medical, and financial variables.
Mitigation strategies can promote fairer health outcomes.
Abstract
Predictive machine learning (ML) models are computational innovations that can enhance medical decision-making, including aiding in determining optimal timing for discharging patients. However, societal biases can be encoded into such models, raising concerns about inadvertently affecting health outcomes for disadvantaged groups. This issue is particularly pressing in the context of substance use disorder (SUD) treatment, where biases in predictive models could significantly impact the recovery of highly vulnerable patients. In this study, we focus on the development and assessment of ML models designed to predict the length of stay (LOS) for both inpatients (i.e., residential) and outpatients undergoing SUD treatment. We utilize the Treatment Episode Data Set for Discharges (TEDS-D) from the Substance Abuse and Mental Health Services Administration (SAMHSA). Through the lenses of…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEthics and Social Impacts of AI · Innovation Policy and R&D
